CIS
NVO

Capital International Sarl’s Novo Nordisk NVO Stock Holding History

Capital International Sarl’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$957K Sell
19,961
-54
-0.3% -$2.32K 0.01% 238
2026
Q1 		$736K Buy
20,015
+11,452
+134% +$543K 0.01% 240
2025
Q4 		$436K Hold
8,563
– – 0.01% 282
2025
Q3 		$475K Sell
8,563
-35,881
-81% -$2.1M 0.01% 263
2025
Q2 		$3.07M Buy
44,444
+10,937
+33% +$744K 0.06% 173
2025
Q1 		$2.33M Buy
33,507
+1,873
+6% +$155K 0.05% 188
2024
Q4 		$2.72M Buy
31,634
+809
+3% +$87.5K 0.06% 166
2024
Q3 		$3.67M Buy
30,825
+4,316
+16% +$576K 0.09% 145
2024
Q2 		$3.78M Sell
26,509
-557
-2% -$73.8K 0.12% 142
2024
Q1 		$3.48M Buy
27,066
+1,834
+7% +$218K 0.12% 149
2023
Q4 		$2.61M Buy
25,232
+957
+4% +$94.6K 0.1% 167
2023
Q3 		$2.21M Sell
24,275
-8,245
-25% -$726K 0.1% 165
2023
Q2 		$2.63M Sell
32,520
-716
-2% -$58.5K 0.12% 158
2023
Q1 		$2.64M Buy
33,236
+6,176
+23% +$438K 0.13% 159
2022
Q4 		$1.83M Buy
27,060
+4,400
+19% +$258K 0.13% 164
2022
Q3 		$1.13M Buy
22,660
+9,922
+78% +$532K 0.09% 183
2022
Q2 		$710K Buy
+12,738
New +$707K 0.06% 194

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Sarl's NVO Position: Q2 2026 in Review

Capital International Sarl reduced its Novo Nordisk (NVO) stake by 0.27% in Q2 2026, selling an estimated $2.32K and leaving 19,961 shares worth $957K. The position accounts for 0.01% of the portfolio, ranked #238.

Capital International Sarl first reported a position in NVO in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.78M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Capital International Sarl held 19,961 shares of Novo Nordisk worth $957K as of Q2 2026.
  • Capital International Sarl sold 54 Novo Nordisk shares in Q2 2026, an estimated $2.32K.
  • Novo Nordisk made up 0.01% of Capital International Sarl's portfolio in Q2 2026, its #238 holding.
  • Capital International Sarl first reported a position in Novo Nordisk in Q2 2022 and has held it in 17 quarters since.
  • Capital International Sarl's Novo Nordisk position peaked at $3.78M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.